Skip to content

Nutex Health Inc. NUTX Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin50.8%+9.9pp40.9%+26.9pp14%-12.4pp26.5%-67.6pp
Operating margin31.5%+4.3pp27.2%+40.0pp-12.8%+173pp-185.4%-231pp
Net margin8.1%-2.8pp10.9%+29.4pp-18.5%+175pp-193.7%-248pp
EBITDA margin33.8%+2.7pp31.2%+36.9pp-5.7%+174pp-179.4%-229pp
Free cash flow margin28.1%+23.6pp4.4%+7.7pp-3.3%
Returns
Return on equity30.7%-23.2pp53.8%+112pp-58.2%+345pp-403.6%
Return on assets9%-0.9pp9.9%+20.9pp-11%+91.8pp-102.8%-170pp
Return on invested capital44%+13.4pp30.6%+40.4pp-9.8%+130pp-139.3%
Efficiency
Asset turnover1.1×+0.2×0.9×+0.3×0.6×+0.1×0.5×-0.7×
Liquidity
Current ratio3.4×+1.5×1.9×+0.3×1.6×-0.2×1.8×-2.3×
Quick ratio3.4×+1.5×1.9×+0.4×1.5×-0.2×1.7×-2.3×
Cash ratio1.2×+0.9×0.3×-0.1×0.4×-0.2×0.6×-0.3×
Leverage
Debt-to-equity1.1×-1.5×2.5×-1.9×4.4×+1.5×2.9×+1.4×
Debt-to-assets0.4×-0.1×0.5×-0.2×0.7×0.0×0.6×+0.2×
Net debt / EBITDA0.6×-1.4×
Interest coverage12.4×+5.8×6.6×+8.5×-1.9×+30.6×-32.6×-55.0×
Valuation
Market capitalization$1.02B+62.2%$172.3M+42.7%$120.74M-90.2%$1.23B-49.6%
Enterprise value$1.15B+32.0%$468.4M+26.2%$371.12M-74.9%$1.48B-42.8%
Price / earnings10.5×+2.0×3.3×
Price / sales1.2×+0.2×0.4×-0.1×0.5×-5.1×5.6×-4.3×
Price / book-0.2×1.3×-0.7×-10.9×12.9×-8.5×
EV / EBITDA3.9×+0.1×3.1×
EV / sales1.3×-0.1×-0.5×1.5×-5.2×6.7×-3.7×
Free cash flow yield26.2%+15.2pp12.3%+19.1pp-6.8%
Earnings yield9.4%-2.3pp30.3%+68.2pp-37.9%-3.5pp-34.4%-39.8pp
PEG ratio0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Nutex Health Inc.'s profit margins?
Nutex Health Inc. (NUTX) runs a 47.5% gross margin and a 31.4% operating margin, with a 11.0% net margin.
Where do Nutex Health Inc.'s ratios come from?
Every ratio is computed from Nutex Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.